Showing results (1-10 of 99) with videos related to
Sort By:
Pageof 10
Seminars in Hematology|December 10, 2023
Antibody and immunotherapy in diffuse large B-cell lymphomaAllison Barraclough, Eliza A HawkesBlood|February 12, 2025
Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphomaCameron S Lewis, Allison Barraclough, Eliza A HawkesBlood|December 21, 2021
Limited-stage diffuse large B-cell lymphomaEliza A Hawkes, Allison Barraclough, Laurie H SehnBritish Journal of Haematology|March 11, 2021
The diagnostic and therapeutic challenges of Grade 3B follicular lymphomaAllison Barraclough, Mark Bishton, Chan Y Cheah, et al.British Journal of Haematology|April 14, 2021
Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 yearsZoe Loh, Ross Salvaris, Geoffrey Chong, et al.British Journal of Haematology|October 13, 2024
The value of semiquantitative PET features and end-of-therapy PET in grade 3B follicular lymphomaAllison Barraclough, Sze Ting Lee, Diego Villa, et al.British Journal of Haematology|April 6, 2024
Learnings from phosphatidylinositol 3-kinase inhibitors in lymphoma-Moving to a model where less can be moreArina Martynchyk, Eliza A HawkesClinical Lymphoma, Myeloma & Leukemia|June 14, 2025
SOHO State of the Art Updates and Next Questions | Does Limited Stage Diffuse Large B-cell Lymphoma Matter?Arina Martynchyk, Eliza A HawkesLeukemia & Lymphoma|May 24, 2012
Diagnosis and management of rare gastrointestinal lymphomasEliza A Hawkes, Andrew Wotherspoon, David CunninghamThe Lancet. Oncology|May 7, 2015
Programmed cell death-1 inhibition in lymphomaEliza A Hawkes, Andrew Grigg, Geoff ChongPageof 10